Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | d299162_ex21-1.htm |
| EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | d299162_ex31-02.htm |
| EX-32.01 - EX-32.01 - ALBIREO PHARMA, INC. | d299162_ex32-01.htm |
| EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | d299162_ex31-01.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | d299162_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Board of Directors and Stockholders
Biodel Inc.
Danbury, Connecticut
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-182877 and 333-188576) and the Registration Statements on Form S-8 (Nos. 333-144407, 333-168903 and 333-180409) of Biodel Inc. of our report dated December 22, 2015, relating to the consolidated financial statements, which appears in this Form 10-K for the year ended September 30, 2015.
/s/BDO USA, LLP
New York, New York
December 22, 2015